Contractor views

Painted into a corner?

Moved by Matisse, Sid Dajani wishes politicians could be as creative in their approach to the NHS.  

Now we've lost the argument...

Our correspondent wants to see a change of tune from pharmacy’s representative bodies.

An Onlooker's Notebook - June 2017

I was not surprised to read that Sue Sharpe had decided to call it a day as chief executive of the PSNC at the end of the year.

Fair and square?

The push for local commissioning is laudable, but how can it possibly work, asks Mukesh Lad, chairman of the LIPCO federated group

MAS a victim of success

Cutting back on the succesful Minor Ailments Service in his area – if combined with a ban on the prescribing of OTCs – will add to the pressure on A&Es, says LPC chairman Dilip Joshi

The frustration game

What we all need right now is a dose of good leadership, says Sid Dajani in latest installment of the Bishopstoke Chronicles

Lessons from Hungary

LPC chairman Dilip Joshi casts an enviable eye over pharmacies in Budapest.

Starting the QPS journey

Independents have a chance to claw back some money via the Quality Payments Scheme, and they ignore this at their peril, says Mukesh Lad

View from the front

Incensed proprietor Sid Dajani finds an official’s briefing on the cuts hard to swallow.  

Crying out for common sense

Sid Dajani gets distracted by a meeting about Healthy Living Pharmacy.

The way ahead

As many readers of this column will be aware, Pharmacy Voice will cease to operate in a few months’ time. At this point we are still deciding how and when. The constitution of the company does not allow for it to continue when one of the three member associations (NPA, AIMp and CCA) has given notice, as the NPA did at the end of 2016. Whether Pharmacy Voice exists as the vehicle to support, represent and deliver change on behalf of the community pharmacy sector is no longer the issue. The question is whether the sector still has an important journey to go on collectively, and if so how does it find a new mode of transport when the Pharmacy Voice vehicle is left by the roadside.

Hunt talks tripe

Jeremy’s been at it again – patronising community pharmacy. He’s been telling Parliament that the NHS should not “continue to subsidise pharmacies that are very close to other pharmacies”. It doesn’t make sense, he insisted, claiming that 40 per cent of pharmacies are in clusters of three or more. And, as with the rest of the NHS, community pharmacy has to make efficiency savings. According to him, the government’s “reforms” are “designed to ensure that, where there is only one local pharmacy that people can access, that pharmacy is protected”.

Plus and minus in December

Thursday December 1The dreaded cuts come into effect today in spite of our collective efforts, resulting in a flurry of activity by pharmacy organisations. The NPA has been at the forefront of campaigning, raising an unprecedented 2.2m signatures opposing cuts through community pharmacies in England. I speak to several colleagues, whose views range from anger to disbelief. Many did not expect the cuts to be implemented as proposed, hoping for a last-minute reprieve or, at least, some concession.

An institutional prejudice

Seeing an article in the Daily Telegraph of December 27, 2016 by the chief nursing officer at NHS England (Jane Cummings) about doing more to treat patients at home made me wonder whether Keith Ridge, the chief pharmaceutical officer, would be able to write an equivalent piece. Ms Cummings makes much of the great pressures the NHS is facing and about it having to adapt to meet the ever-growing demands on it. She talks of more resources going into general practice and other facilities. What would Dr Ridge be able to write?

Never hurray a Murray

It took him long enough, didn’t it? It’s been 12 years since Keith Ridge was appointed as chief pharmaceutical officer at the Department of Health and finally he’s managed to clear his in-tray and get round to commissioning an independent report on clinical services in community pharmacy – by the director of policy at the King’s Find, Richard Murray. It’s hard to believe, isn’t it? I mean, I know it takes a while to settle into a new job, and I’m sure the poor chap has had his plate full, but you would have thought that with all the problems the NHS is facing at the moment he would have been busier than ever. Still, better late than never, eh?

Going, going, gone!

It has been an enormous privilege and I have been fortunate enough to be asked to speak at several weddings, forums all over the world, and even three eulogies. Two of these requests came from patients’ families, and at the last one the priest joked he was scared because it sounded like I could do his job! But an old university friend who’d been let down at the last minute gave me a unique invitation that I couldn’t refuse. We met at her local town hall, which was stuffed to the gunwales with people who’d donated prizes. There were dozens of them, and I know because I was the auctioneer.

Lessons from Borgen and a New Year message

Onlooker compares BBC4 drama Borgen to events at the Pharmaceutical Journal

Cuts and more cuts

Wednesday November 2 I am at the LPC Conference at the Congress Centre in London today and am surprised the health minister, David Mowat, attends and is robust in announcing that cuts will go ahead in the face of a lukewarm reception from delegates. He states an intention to move community pharmacy into a future shaped around services largely commissioned locally, admitting that this will be easier to bring about in some areas than others. Sue Sharpe speaks of betrayal by the DH’s disregard of the value of community pharmacy and dismissal of concerns of patients who rely on the care provided by community pharmacy teams.

Paying through the nose

Last month we heard the unedifying news that pharmaceutical companies were ripping off the NHS by charging inflated prices for generic medicines. The practice was first revealed in June 2016 by The Times, but it took a further six months for the Competition and Markets Authority (CMA) to announce its decision to fine Pfizer a record £84.2m and Flynn Pharma an additional £5.2m for charging “excessive and unfair prices” for phenytoin capsules. It seems incredible that generic medicines can be priced at levels many times higher than the cost of the original branded product.

Did Christmas come early?

Just this week, NHS England published its independent review of community pharmacy clinical services that was undertaken by Richard Murray of the King’s Fund. I wish I could be encouraged by it, but I’m feeling too disheartened by the way we’ve been treated this year. On the face of it, there’s abundant good news, but I don’t see how the report’s recommendations can be implemented without significant investment. We read that renewed efforts are needed “to make the most of the existing clinical services that community pharmacy can provide and to do so at pace”. Great!

Previous 1 2 3 4 5 6 7 Next

Latest News

Brexit crisis: Pharmacies must be given special powers

The NPA warns pharmacists must be given powers to supply medicines after government’s Commons defeat.

Real-time exemption checking may have problems

The real-time exemption checking system may not be perfect, warns Sandra Gidley.    

Opinion

Brexit crisis: Pharmacies must be given special powers

The NPA warns pharmacists must be given powers to supply medicines after government’s Commons defeat.

Popular Features

Self-pay not self-pity!

Frustration with NHS waiting lists has seen more people pay for their own healthcare. Should pharmacies take note?

Invest in your employees’ training

Training can boost employee engagement levels, improve performance and help retain key talent.

PDA: GPhC failing to take progressive regulation approach

PDA accuses GPhC of missing opportunities to support more progressive approach to regulation.



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.